Document Detail


Design and synthesis of novel inhibitors of human kynurenine aminotransferase-I.
MedLine Citation:
PMID:  22281190     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Herein we report 6-ethoxy-6-oxo-5-(2-phenylhydrazono) hexanoic acid and 3-(2-carboxyethyl)-1H-indole-2-carboxylic acid derivatives as synthetically accessible leads for human kynurenine aminotransferase-I (KAT-I) inhibitors. In total, 12 compounds were synthesized and their biological activities were determined using the HPLC-UV based KAT-I inhibition assay. Of the 12 compounds synthesized, 10 were found to inhibit human KAT-I and the most active compound was found to be 5-(2-(4-chlorophenyl) hydrazono)-6-ethoxy-6-oxohexanoic acid (9a) with an IC(50) of 19.8μM.
Authors:
Fady N Akladios; Naveed A Nadvi; Joohong Park; Jane R Hanrahan; Vimal Kapoor; Mark D Gorrell; W Bret Church
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-10
Journal Detail:
Title:  Bioorganic & medicinal chemistry letters     Volume:  -     ISSN:  1464-3405     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107377     Medline TA:  Bioorg Med Chem Lett     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Affiliation:
Faculty of Pharmacy A15, The University of Sydney, Sydney NSW 2006, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  SAR of ?7 nicotinic receptor agonists derived from tilorone: Exploration of a novel nicotinic pharma...
Next Document:  Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore childre...